Nils‐Olov Bodin

485 citations
12 papers · 392 indexed · h-index 10
Topics
Analytical Methods in Pharmaceuticals (4 papers)Antibiotics Pharmacokinetics and Efficacy (3 papers)Analytical Chemistry and Chromatography (2 papers)

In The Last Decade

Nils‐Olov Bodin

12 papers receiving 328 citations

Peers

Nils‐Olov Bodin
Comparison fields: 5 of 86
  • Pharmacology 86
  • Pharmacology 84
  • Genetics 81
  • Molecular Biology 69
  • Surgery 65
Replace A Arancibia with:
A Arancibia Chile
David B. Haughey United States
J H Lin United States
Dag E. S. Campbell Sweden
Howard Ko United States
M Royer United States
F A deLuna United States
Francisca Torres‐Molina Spain
Henry J. Pieniaszek United States
D. P. Thornhill United Kingdom
Nils‐Olov Bodin relative to A Arancibia Chile A Arancibia's profile →
Citations per field
00.5×1.5×2.0×
A Arancibia · 1×
Citations per year

Countries citing papers authored by Nils‐Olov Bodin

Since Specialization
Citations

This map shows the geographic impact of Nils‐Olov Bodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils‐Olov Bodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils‐Olov Bodin more than expected).

Fields of papers citing papers by Nils‐Olov Bodin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils‐Olov Bodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils‐Olov Bodin. The network helps show where Nils‐Olov Bodin may publish in the future.

Co-authorship network of co-authors of Nils‐Olov Bodin

This figure shows the co-authorship network connecting the top 25 collaborators of Nils‐Olov Bodin. A scholar is included among the top collaborators of Nils‐Olov Bodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils‐Olov Bodin. Nils‐Olov Bodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 136
3 9
4 12
5 9
6 68
7 21
8 31
9 9
10 68
11 21
12 7

About Nils‐Olov Bodin

Nils‐Olov Bodin is a scholar working on Analytical Chemistry, Molecular Medicine and Pharmacology, having authored 12 papers that have together received 392 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Pharmacology (84 citations), Pharmacology (86 citations) and Analytical Chemistry (37 citations). Nils‐Olov Bodin has collaborated with scholars based in Sweden, Russia and United States. Frequent co-authors include J K Aronson, C P Willoughby, S. C. Truelove, Emma Hansson, Göran Magnusson, Åke Ryrfeldt, L. Magni, Bertil Ekström, Berndt Sjöberg and K. O. Borg. Their work appears in journals such as Gut, Antimicrobial Agents and Chemotherapy and Cellular and Molecular Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026